The Basics

Stem cells are undifferentiated precursor cells that can perpetuate themselves as stem cells (called self renewal), or that can differentiate into many different specialized cell types, such as heart muscle cells. Stem cells are at the center of the new field of regenerative medicine.

Stem cells have been proposed as treatments for many human diseases. The diseases most likely to benefit from stem cell therapy include heart disease, stroke, Alzheimer’s, Parkinson’s, macular degeneration, cancer and other serious human diseases. Stem cells could potentially reduce the need for organ transplants and related surgeries.

Stem cells are found in the human body in many different tissues including bone marrow, heart, brain, pancreas, blood, skeletal muscle, fat, and skin. Adult stem cells have been used to treat human disease for more than forty years, beginning with their use in bone marrow transplant. In the late 1990’s reports from diverse scientific disciplines suggested that bone marrow stem cells may have applications to other diseases outside of blood cancer, thereby radically transforming their clinical utility. Adult bone marrow stem cells are now being investigated in over 50 clinical studies outside of the blood cancer diseases (listed at www.clinicaltrials.gov). Clinical trials have already demonstrated the safety of these cells in heart disease and stroke, and well designed and controlled Phase II clinical trials have also shown that stem cell therapy improves mortality in heart disease.

Although clinical trials have shown the potential of adult stem cell therapies, limitations with the current treatment methods have been identified both clinically and in animal models. Stem cells preferentially accumulate in clearing sites in the spleen and liver, even when the stem cells are injected directly into the target organ. The current frontiers in regenerative medicine and stem cell therapy are stem cell delivery and organ retention.


 Email Page    Print
Disclaimer
IMPORTANT DISCLAIMER: THE INFORMATION CONTAINED IN THE COMPANY'S WEB SITE HAS BEEN PREPARED BY MANAGEMENT OF THE COMPANY WHO TAKES FULL RESPONSIBILITY FOR ITS CONTENTS.  NO SECURITIES REGULATORY AUTHORITY HAVING JURISDICTION OVER THE COMPANY OR EXCHANGE OR OVER-THE-COUNTER MARKET UPON WHICH THE COMPANY'S SECURITIES ARE PRESENTLY POSTED FOR TRADING HAS EITHER APPROVED NOR DISAPPROVED OF THE COMPANY'S WEB SITE OR THE CONTENTS OF THE INFORMATION CONTAINED IN THE COMPANY'S WEB SITE.

IN ADDITION, THE INFORMATION CONTAINED IN THE COMPANY'S WEB SITE DOES NOT, UNDER ANY CIRCUMSTANCES, CONSTITUTE A DISTRIBUTION OF ANY SECURITIES OF THE COMPANY IN ANY JURISDICTION WHATSOEVER AND SHALL NOT CONSTITUTE AN OFFER TO SELL, OR THE SOLICITATION OF AN OFFER TO BUY, ANY SECURITIES OF THE COMPANY, NOR SHALL THERE BE ANY SALE OF ANY SECURITIES OF THE COMPANY IN ANY JURISDICTION IN WHICH SUCH OFFER, SOLICITATION OR SALE WOULD BE UNLAWFUL PRIOR TO REGISTRATION OR QUALIFICATION UNDER THE SECURITIES LAWS OF ANY SUCH JURISDICTION.  FURTHERMORE, THE INFORMATION CONTAINED IN THE COMPANY'S WEB SITE IS NOT DIRECTED AT ANY PARTICULAR RESIDENTS OF ANY JURISDICTION.

THE INFORMATION CONTAINED IN THE COMPANY'S WEB SITE MAY INCLUDE 'FORWARD-LOOKING STATEMENTS', AS THAT TERM IS DEFINED IN SECTION 27A OF THE SECURITIES ACT OF 1933, AS AMENDED, AND SECTION 21E OF THE SECURITIES EXCHANGE ACT OF 1934.  STATEMENTS CONTAINED IN THE COMPANY'S WEB SITE MAY INCLUDE INFORMATION WHICH IS NOT PURELY HISTORICAL, ARE FORWARD-LOOKING STATEMENTS AND INCLUDE ANY STATEMENTS REGARDING BELIEFS, PLANS, EXPECTATIONS OR INTENTIONS REGARDING THE FUTURE.  ACTUAL RESULTS COULD DIFFER FROM THOSE PROJECTED IN ANY FORWARD-LOOKING STATEMENTS DUE TO NUMEROUS FACTORS.  THESE FORWARD-LOOKING STATEMENTS ARE MADE AS OF THE DATE OF THE COMPANY'S WEB AND THE COMPANY ASSUMES NO OBLIGATION TO UPDATE THE FORWARD-LOOKING STATEMENTS, OR TO UPDATE THE REASONS WHY ACTUAL RESULTS COULD DIFFER FROM THOSE PROJECTED IN THE FORWARD-LOOKING STATEMENTS. ALTHOUGH THE COMPANY BELIEVES THAT THE BELIEFS, PLANS, EXPECTATIONS AND INTENTIONS CONTAINED IN THE COMPANY'S WEB ARE REASONABLE, THERE CAN BE NO ASSURANCE THOSE BELIEFS, PLANS, EXPECTATIONS OR INTENTIONS WILL PROVE TO BE ACCURATE.  INVESTORS SHOULD CONSIDER ALL OF THE INFORMATION SET FORTH HEREIN AND SHOULD ALSO REFER TO THE RISK FACTORS DISCLOSED IN THE COMPANY'S PERIODIC REPORTS FILED FROM TIME-TO-TIME WITH THE SECURITIES AND EXCHANGE COMMISSION.